Insider Transactions in Q2 2017 at Merck & Co., Inc. (MRK)
Insider Transaction List (Q2 2017)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 12
2017
|
C Robert Kidder Director |
SELL
Open market or private sale
|
Direct |
5,000
-34.92%
|
$315,000
$63.54 P/Share
|
|
May 12
2017
|
C Robert Kidder Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+25.88%
|
$175,000
$35.19 P/Share
|
|
May 09
2017
|
Robert M Davis Chairman, CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
44,530
-37.73%
|
$2,849,920
$64.01 P/Share
|
|
May 09
2017
|
Robert M Davis Chairman, CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct |
85,881
+42.12%
|
-
|
|
May 09
2017
|
Adele D Ambrose Sr.V-P & Chief Comuns Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
960
-4.06%
|
$61,440
$64.01 P/Share
|
|
May 09
2017
|
Adele D Ambrose Sr.V-P & Chief Comuns Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,576
+9.82%
|
-
|
|
May 09
2017
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
960
-5.62%
|
$61,440
$64.01 P/Share
|
|
May 09
2017
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
2,576
+13.11%
|
-
|
|
May 02
2017
|
Julie L. Gerberding EVP, Chief Patient Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,078
-2.32%
|
$66,836
$62.38 P/Share
|
|
May 02
2017
|
Julie L. Gerberding EVP, Chief Patient Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,092
+6.25%
|
-
|
|
May 02
2017
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
SELL
Payment of exercise price or tax liability
|
Direct |
974
-2.23%
|
$60,388
$62.38 P/Share
|
|
May 02
2017
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
BUY
Exercise of conversion of derivative security
|
Direct |
3,092
+6.62%
|
-
|
|
Apr 03
2017
|
Adam H Schechter EVP & Pres-Global Human Health |
SELL
Open market or private sale
|
Indirect |
53,850
-31.64%
|
$3,392,550
$63.48 P/Share
|